CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

August 11, 2022 · earnings

SLS earnings: a negative outcome, -5.6%

On August 11, 2022, SELLAS Life Sciences Group, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.6% in the window around the event. It had already run +22.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$3.38
1d before
$3.19
Event day
$3.10
1d after
$3.16
5d after

Pre-catalyst setup

+22.4%
30-day run-up
4841%
30-day volatility
1.7×
volume spike